ReviewHealth science reports2025
Glaucoma Disease-Specific Adherence Measurement Tools Validated for Measuring Adherence to Glaucoma Medications: A Systematic Review.
Review in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reviewing validated glaucoma disease-specific tools for measuring adherence could encourage adherence monitoring to avoid progressive visual field losses in people living with glaucoma. Aim: To review the literature on validated disease-specific tools for measuring adherence to glaucoma medications. Methods: Relevant peer-reviewed publications from the year 2000 to 2022 from PubMed, EMBASE, Scopus, and PROquest were retrieved. For each search conducted, the name of the search engine used, date of search, number of publications retrieved, and keywords used were documented. The selected articles were reviewed for inclusion and assessed for biases and quality. Each tool was described by the type of measurement, technique for measurement, strengths and weaknesses, and method of validation, respectively. Results: Out of the 10 included articles, seven glaucoma disease-specific tools were identified namely; Glaucoma Treatment Compliance Assessment Tool-Short form (GTCAT-S), Glaucoma Treatment Compliance Assessment Tool-Long form (GTCAT-L), Travatan Dosing Aid (TDA), Eye-Drop Satisfaction Questionnaire (EDSQ), Glaucoma Adherence Questionnaire-Revised (GAQ-R), Glaucoma Adherence Questionnaire-Old (GAQ-O), and Schwartz Adherence Questionnaire (SAQ). Three studies had a low risk of bias, and seven recorded a moderate risk of bias. The TDA, GTCAT-S, and GTCAT-L were rated as high-quality tools. Conclusions: Seven glaucoma disease-specific tools for measuring adherence were found. Integration of regular measurement of medication adherence as part of care for glaucoma patients would be beneficial for both patients and providers of eye care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.